PIK3CD Gene

PIK3CD Gene

Gene Overview

PIK3CD Gene

Gene Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PIK3CD Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PIK3CD</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PIK3CD</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=PIK3CD" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">63 edges</a></td>
</tr>
</table>

PIK3CD (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta) encodes the p110delta protein, the catalytic subunit of class IA phosphoinositide 3-kinase (PI3K). While classically considered a leukocyte-restricted isoform, p110delta is increasingly recognized as playing important roles in brain-resident immune cells and in neuroinflammatory processes that contribute to neurodegenerative disease pathogenesis["@wang2022"].

The p110delta isoform is predominantly expressed in immune cells including T cells, B cells, natural killer cells, mast cells, and macrophages. In the central nervous system, p110delta is primarily expressed in microglia, the brain's resident immune cells. Microglial PI3Kdelta signaling regulates inflammatory responses, phagocytosis, and cell survival—processes critical to neurodegeneration["@yue2022"].

Gene Structure and Protein

Genomic Organization

The human PIK3CD gene is located on chromosome 1p36.22 and spans approximately 25 kilobases. It encodes a protein of 1,048 amino acids with a molecular weight of approximately 110 kDa.

p110δ Protein Structure

The p110δ catalytic subunit contains several conserved domains:

• p85-binding domain: Interacts with p85 regulatory subunits (PIK3R1, PIK3R2) that control enzyme activity and localization
• C2 domain: Binds to cellular membranes through interactions with phospholipids
• Helical domain: Involved in protein-protein interactions
• Kinase domain: The catalytic center that phosphorylates PIP2 to generate PIP3

Expression and Cellular Distribution

Immune Cell Expression

p110δ is highly expressed in:

• T lymphocytes: Critical for T cell receptor signaling, proliferation, and differentiation
• B cells: Required for B cell receptor signaling and antibody production
• Natural killer cells: Important for cytotoxic function
• Macrophages: Regulates phagocytosis and inflammatory responses
• Mast cells: Controls degranulation and allergic responses

Brain Expression

In the central nervous system, p110δ is expressed primarily in microglia[@yue2022]:

• Microglial p110δ: Regulates microglial activation, cytokine production, and phagocytosis
• Neuronal expression: Low or negligible under normal conditions
• Astrocyte expression: Minimal compared to microglia

Role in Neuroinflammation

Microglial Activation

PI3Kδ signaling in microglia regulates the transition between surveillance (homeostatic) and activated states:

Pro-inflammatory activation: p110δ contributes to signaling cascades that drive production of pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α. Inhibition of p110δ reduces microglial inflammatory responses[@yue2022].

Phagocytosis: PI3Kδ regulates the cytoskeletal changes required for phagocytosis of cellular debris, amyloid-beta plaques, and pathogens. This function is double-edged—effective phagocytosis is protective, but excessive phagocytosis can contribute to synaptic loss.

Cell survival: p110δ-mediated Akt activation promotes microglial survival. In chronic neuroinflammation, microglial apoptosis can lead to loss of surveillance and repair functions.

T Cell-Mediated Neuroinflammation

Peripheral T cells can infiltrate the brain in neurodegenerative diseases. p110δ is critical for:

• T cell activation and proliferation
• Th1/Th2 differentiation
• Regulatory T cell function

Alzheimer's Disease

Amyloid-Beta Clearance

Microglial p110δ plays a dual role in Aβ metabolism[@huang2021][@zhang2020]:

Protective functions: p110δ-mediated signaling is required for effective microglial Aβ phagocytosis. Knockdown of p110δ impairs clearance.

Pathogenic functions: Chronic p110δ activation drives excessive inflammation that damages neurons and may impair the brains's native clearance mechanisms.

This duality makes p110δ targeting complex—complete inhibition might impair beneficial phagocytosis.

Therapeutic Inhibition

PI3Kδ inhibitors have shown promise in preclinical AD models:

• Reduced inflammatory cytokines: Lower IL-1β, TNF-α in brain
• Improved neuronal survival: Reduced apoptosis markers
• Better cognitive outcomes: Improved performance in behavioral tests

Parkinson's Disease

Microglial Activation in PD

In Parkinson's disease, microglial activation contributes to dopaminergic neuron death:

• Pro-inflammatory mediators: Enhanced production of cytokines and reactive oxygen species
• Phagocytic dysfunction: Impaired clearance of alpha-synuclein aggregates
• Sustained activation: Chronic neuroinflammation drives progressive degeneration

Therapeutic Potential

p110δ inhibition represents a strategy to modulate microglial inflammation in PD[@kang2023]:

• Reduces cytokine production
• May improve alpha-synuclein clearance by shifting microglial phenotype
• Protects dopaminergic neurons in model systems

p110δ Versus Other PI3K Isoforms

p110δ vs p110α

• Expression: p110δ is immune-restricted; p110α is ubiquitous
• Function: p110δ primarily in immune cells; p110α in growth factor signaling
• Therapeutic targeting: p110δ inhibition is immune-specific; p110α affects many tissues

p110δ vs p110β

• p110β: More broadly expressed, important in platelet function and some cancers
• p110δ: More specific to immune cells
• Isoform-selective inhibitors: Achieve immune specificity with p110δ-selective compounds

Isoform-Selectivity Considerations

The therapeutic window for p110δ inhibition depends on:

• Achieving sufficient brain penetration
• Avoiding complete immune suppression
• Balancing anti-inflammatory versus immunosuppressive effects

Clinical Development

Drug Candidates

Several PI3Kδ inhibitors have been developed:

• Idelalisib: FDA-approved for hematological malignancies
• Parsaclisib: In development for autoimmune conditions
• Selectively brain-penetrant compounds: Under development for CNS indications

Challenges

Key challenges for neuroinflammation indications:

• Blood-brain barrier penetration: Many compounds don't reach effective brain concentrations
• Peripheral immunosuppression: Increased infection risk
• Dosing regimen: Balancing efficacy with safety

Clinical Trials

PI3Kδ inhibitors have shown efficacy in:

• Autoimmune diseases (idelalisib for lymphoma, others for autoimmune conditions)
• Preclinical neurodegeneration models
• Upcoming trials expected in AD and PD

Genetic Considerations

PIK3CD Variants

• Rare loss-of-function variants cause immunodeficiency (APDS syndrome)
• No common variants strongly linked to neurodegeneration risk
• Expression quantitative trait loci may influence disease severity

Therapeutic Implications

Understanding PIK3CD genetics informs:

• Patient selection for clinical trials
• Safety monitoring for immune-related adverse events
• Combination therapy approaches

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [PI3K/Akt Signaling](/mechanisms/pi3k-akt-signaling)
• [Microglia](/cell-types/microglia)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Amyloid-Beta](/proteins/amyloid-beta)

External Links

• [NCBI Gene: PIK3CD](https://www.ncbi.nlm.nih.gov/gene/)
• [UniProt: P110D_HUMAN](https://www.uniprot.org/uniprot/)
• [KEGG: PI3K-Akt signaling pathway](https://www.genome.jp/kegg/pathway.html)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving PIK3CD Gene discovered through SciDEX knowledge graph analysis: